Browsing Category

Top Industry News

7537 posts

Sanofi To Invest $20 Bn in US-Based R&D & Mfg Ops 
By

By
Sanofi has announced its intention to invest at least $20 billion in the US through 2030.  Although not detailing specifics, the company says that “the expected investment includes a significant increase…

Supplier News: Piramal, Famar, Recipharm & Ecolab 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Piramal Pharma, Famar Group, Recipharm/ProductLife Group and Ecolab Life Sciences.   Biologics Manufacturing * Ecolab Opens New Bioprocessing Lab Formulation Development/Drug Product Manufacturing * Famar To…

M&A News: GSK, bluebird bio & More 
By

By
The latest news on mergers and acquisitions featuring GSK/Boston Pharmaceuticals and bluebird bio/Carlyle/SK Capital Partners. Highlights below.  * GSK To Acquire Liver Disease Drug from Boston Pharmaceuticals in $2-Bn Deal*…

Partnering News: Novo Nordisk, AbbVie, Lilly & More 
By

By
A roundup of bio/pharmaceutical partnering news from Novo Nordisk/Septerna, AbbVie/ADARx Pharmaceuticals, and Eli Lilly and Company/Purdue University.  * Novo Nordisk, Septerna in $2.2-Bn Small-Molecule Cardiometabolic Drug Pact* AbbVie, ADARx Pharmaceuticals…

Gilead Sciences Targets $11 Bn More in US Capital Expenditures 
By

By
Gilead Sciences has announced an additional $11 billion in capital and operational investments in the US to supplement an already planned spend of $21 billion in US manufacturing and R&D…

EU Outlines Plan for Tariffs; Announces Increased Science Investments
By

By
The European Commission has taken two additional steps in response to potential tariffs by the US as it negotiates a possible trade deal with the US. This week (May 7,…

FDA Completes First Pilot for Use of AI in Scientific Reviews; Outlines Next Steps 
By

By
The US Food and Drug Administration (FDA) Commissioner, Dr. Martin Makary, reports that FDA has completed its first pilot using artificial intelligence (AI) in the agency’s scientific review process and…

FDA Names New Director to Lead Center for Biologics Evaluation and Research
By

By
The US Food and Drug Administration’s (FDA) Commissioner, Dr. Martin Makary, has named  Vinay Prasad, M.D., M.P.H., a hematologist–oncologist, who most recently served as Professor in the Department of Epidemiology…

Supplier News: Xellia, SK pharmteco, Roquette & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Xellia Pharmaceuticals, SK pharmteco, Roquette, Aptar and Schott Pharma.   Chemicals/Chemical API Manufacturing * Xellia Plans Multi-Year Phase-out of Antibiotic API Mfg In Denmark Biologics…

Global Briefs: Lilly, Ipsen, Shionogi & More 
By

By
A roundup of news from Eli Lilly and Company, Ipsen, Shionogi, Bain Capital, Ratio Therapeutics, and Bavarian Nordic. Highlights below.   Leadership Appointments * Lilly Announces Leadership Changes * Ipsen Appoint EVP, Strategy…